Transcriptome-driven constraint-based modelling reveals metabolic targets for ovarian cancer
Ontology highlight
ABSTRACT: OV56 ovarian cancer cell line treated with siTPI1 (siRNA targeted against triose phosphate isomerase 1) and the following negative controls: NTsiRNA (non-targeting siRNA), transfection reagent only and untreated. Experiment designed to assess the effect of TPI1 gene knockdown on OV56 gene expression.
INSTRUMENT(S): Illumina NovaSeq 6000
ORGANISM(S): Homo sapiens
SUBMITTER: Kate Meeson
PROVIDER: E-MTAB-16770 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA